Anzeige
Mehr »
Lynx Broker
Login
Donnerstag, 22.08.2019 Börsentäglich über 12.000 News von 607 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:42Oncorus raises £65.5m funding to advance oncolytic virus therapies
12:42Mundipharma announces licence extension submission for Invokana and Vokanamet to EMA
10:42GSK submits first regulatory application for daprodustat in Japan
09:42Pfizer to invest £411m in new US gene therapy manufacturing facility
MiBayer to offload animal health business to Elanco for £6.27bn
MiGraybug Vision secures £66m to advance retina and glaucoma clinical programs
MiFDA accepts new drug application for elexacaftor , tezacaftor and ivacaftor combination treatment
MiAstraZeneca's Farxiga meets primary endpoint in phase III heart failure study
DiKnopp begins phase 2 trial for oral dexpramipexole in eosinophilic asthma
DiFDA grants fast track status to Moderna's Zika vaccine
DiAngel-funded Siamab completes £166m exit with large commercial-stage biopharma
MoXynomic Research Institute successfully designs series of potent RET kinase inhibitors
MoAbbVie receives FDA approval of RINVOQ for moderate to severe rheumatoid arthritis
MoCelgene gets FDA approval for myelofibrosis treatment Inrebic
FrEuropean Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis
FrGeneCentric Therapeutics acquires Select ImmunoGenomics
FrRoche gets FDA nod for Rozlytrek to treat ROS1-positive NSCLC
15.08.Lynparza plus bevacizumab meets primary endpoint in PAOLA-1 trial
14.08.Lilly announces superiority of Taltz versus TREMFYA in IXORA-R trial
14.08.Landos Biopharma completes £49.7m series B financing
14.08.Janssen gets EC approval for two new indications of Imbruvica
13.08.Kedrion Biopharma announces enrollment of first patient in CARES10 trial
13.08.Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares
13.08.Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m
12.08.Ascletis opens Clinical Development Shanghai Center